lobbying_activities: 1527574
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1527574 | 2403f9af-befb-43f2-aa95-e4e37bf37c09 | Q1 | GSK (FKA GLAXOSMITHKLINE INC.) | 16293 | GSK (FKA GLAXOSMITHKLINE INC.) | 2014 | first_quarter | TAX | No bill # assigned - Tax reform policy issues, provisions related to corporate tax reform and research and development tax credit | Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1630000 | 0 | 0 | 2014-04-18T14:11:03.963000-04:00 |